Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating venous thromboembolism: enoxaparin.

D J Perry1

  • 1Haemophilia Centre and Haemostasis Unit, Royal Free and University College Medical School, Royal Free Campus, London NW3 2PF.

Hospital Medicine (London, England : 1998)
|January 29, 2002
PubMed
Summary

Low molecular weight heparin is now a proven treatment for venous thromboembolism. Evidence supports shifting venous thromboembolism care from inpatient to outpatient settings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Factor X and its deficiency states.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Laboratory monitoring of haemostasis.

Anaesthesia·2014
Same author

Genetic testing in bleeding disorders.

Haemophilia : the official journal of the World Federation of Hemophilia·2014
Same author

Recurrent pregnancy loss and thrombophilia.

The Ceylon medical journal·2014
Same author

Pollen pool heterogeneity in jack pine (Pinus banksiana Lamb.): a problem for estimating outcrossing rates?

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013

Area of Science:

  • Cardiovascular Medicine
  • Hematology

Background:

  • Venous thromboembolism (VTE) management has evolved significantly over the past decade.
  • Traditional VTE treatment often involved prolonged inpatient stays.

Purpose of the Study:

  • To review advancements in VTE treatment over the last 10 years.
  • To evaluate the evidence for transitioning VTE care to outpatient settings.

Main Methods:

  • Literature review of studies on VTE treatment modalities.
  • Analysis of clinical trial data and healthcare management trends.

Main Results:

  • Low molecular weight heparin (LMWH) has emerged as a highly effective therapeutic agent for VTE.
  • Significant evidence supports the safety and efficacy of outpatient VTE management.

Conclusions:

  • LMWH represents a major therapeutic advance in VTE care.
  • Outpatient management of VTE is a viable and increasingly adopted strategy, improving patient outcomes and resource utilization.

Related Experiment Videos